- Home
- OKUR vs ACV Comparison
OKUR vs ACV Comparison
Compare OKUR & ACV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKUR
- ACV
- Stock Information
- Founded
- OKUR 2011
- ACV 2015
- Country
- OKUR United States
- ACV United States
- Employees
- OKUR N/A
- ACV N/A
- Industry
- OKUR
- ACV Finance/Investors Services
- Sector
- OKUR
- ACV Finance
- Exchange
- OKUR NYSE
- ACV Nasdaq
- Market Cap
- OKUR 234.2M
- ACV 222.0M
- IPO Year
- OKUR N/A
- ACV N/A
- Fundamental
- Price
- OKUR $15.99
- ACV $22.10
- Analyst Decision
- OKUR Strong Buy
- ACV
- Analyst Count
- OKUR 2
- ACV 0
- Target Price
- OKUR $37.50
- ACV N/A
- AVG Volume (30 Days)
- OKUR 58.1K
- ACV 38.8K
- Earning Date
- OKUR 11-07-2024
- ACV 01-01-0001
- Dividend Yield
- OKUR N/A
- ACV 9.20%
- EPS Growth
- OKUR N/A
- ACV N/A
- EPS
- OKUR N/A
- ACV N/A
- Revenue
- OKUR N/A
- ACV N/A
- Revenue This Year
- OKUR N/A
- ACV N/A
- Revenue Next Year
- OKUR N/A
- ACV N/A
- P/E Ratio
- OKUR N/A
- ACV N/A
- Revenue Growth
- OKUR N/A
- ACV N/A
- 52 Week Low
- OKUR $9.80
- ACV $16.82
- 52 Week High
- OKUR $77.60
- ACV $23.74
- Technical
- Relative Strength Index (RSI)
- OKUR N/A
- ACV 60.88
- Support Level
- OKUR N/A
- ACV $21.28
- Resistance Level
- OKUR N/A
- ACV $22.34
- Average True Range (ATR)
- OKUR 0.00
- ACV 0.29
- MACD
- OKUR 0.00
- ACV 0.05
- Stochastic Oscillator
- OKUR 0.00
- ACV 80.75
About OKUR ONKURE THERAPEUTICS INC
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.
About ACV Virtus Diversified Income & Convertible Fund of Beneficial Interest
Virtus AllianzGI Diversified Income & Convertible Fund is a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation while seeking to provide downside protection against capital loss. It seeks to achieve its investment objective by investing in a combination of convertible securities, debt and other income-producing instruments and common stocks and other equity securities.